Keranova introduces its FemtoMatrix technology

This is the first time that a new surgical technique, photoemulsificationwas used that represents an important new step in cataract surgery since the invention of phacoemulsification in the late 1980’s. These particularly positive results will benefit both surgeons and patients. Explanations.

The Keranova company conducted a study with a total of 54 patients in the Czech Republic at the end of the second quarter of 2022. The contralateral eye of each patient was treated with phacoemulsification to serve as a control.

The study showed that the use of FemtoMatrix technology in a standard population meant that in most cases ultrasound could be dispensed with or at least significantly reduced.

Surgeons can thus perform perfectly calibrated cataract surgeries, thus limiting the risks associated with the use of ultrasound during phacoemulsification.

With this new technology You can now operate without ultrasound as efficiently as with current techniques and with increased precision and reduced risk of corneal or iris damage, capsular tears or adverse retinal effects, while maintaining the same uptime “Confirms Keranova’s press release.

Patients (94 million people worldwide; a number expected to increase as the population ages) will be able to benefitsafer, less operator dependent operation with more consistent results.

In practice, this surgical laser allows true photoemulsification of the lens instead of simply pre-cutting into quarters or sticks as suggested by current devices.

This system allows the laser to be precisely and automatically aligned at any point on the lens, and the use of a surgical robot greatly simplifies the procedure.. The device is quick and easy to maneuver and fits easily in the operating room, eliminating the need for surgeon and patient to move during the procedure.

These exceptional results, achieved after six years of intensive work, will enable Keranova to soon offer photoemulsification technology to surgeons. This will be the third generation of cataract surgical technique after extracapsular extraction and phacoemulsification “, explains Fabrice Romano, founder and CEO of Keranova.

And to continue: We will therefore be the first to provide surgeons with a medical device that meets the current technological standards of cataract surgery, with an ultra-fast laser, an element that modifies the laser through photonics, a robot, artificial intelligence that automatically adjusts the energy and a fiber. In short, a device that uses today’s technologies to benefit cataract patients. »

The company’s innovative approach aims to transform cataract surgery by reducing manual procedures in favor of automation and precision to promote reproducibility and reduce clinical risk.

The results are extremely promising: the FemtoMatrix device has been shown to be safe to perform laser cataract surgery without phacoemulsification in less than eight minutes in a single operating room, which is impossible with current techniques. adds dr Damien Gatinel, Head of the Department of Refractive Surgery and Anterior Section of the Ophthalmology Department of the Rothschild Foundation (Paris) and member of the Keranova Scientific Advisory Board.

From now on Keranova is aiming to get the CE mark for its device in 2023which will make it possible to market a first version of the FemtoMatrix.

*Keranova develops next-generation surgical devices in ophthalmology using photonics-based technology to develop ultra-fast medical lasers.


Leave a Comment